New KRAS mutation discovery opens door to targeted colon cancer therapies

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene – a gene that can cause cancer – that may play an important role in colon cancer. Researchers also showed how this mutation could be targeted therapeutically.